 CARLSBAD, Calif., Dec. 18, 2020 PRNewswire -- Qualigen Therapeutics, Inc. Nasdaq: QLGN today announced the closing of its previously announced registered direct offering with a single institutional investor for the purchase and sale for 12,000,000 of i 2,370,786 shares of common... 